Company / Net Debt per Share
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Net Debt per Share History
FY2016-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Debt per Share
$2.55
FY2022
5-year range
$2.13 / $2.55
FY2018-FY2022
Trend
+19.4%
vs FY2021
Sector context
#65 of 98
Health Care
What the data says
At $2.55, PACIFIC BIOSCIENCES OF CALIFORNIA, INC.'s net debt per share ranks #34 of 98 in the Health Care sector. Increased from $-0.09 to $2.55 over the past 3 years.
Based on SEC 10-K filings.
2.55 in FY2022.
Increased from $-0.09 to $2.55 over the past 3 years.
Health Care sector context is included.
Net Debt per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#34 of 98 in Health CareTop 34% of 98This company $2.55 Sector average $7.39
▼
-65.6% below sector average
Key checks
Key Insights
- In FY2022, net debt per share increased 19.4% year-over-year.
- Ranks #65 out of 98 companies in the Health Care sector.
- Lowest net debt per share in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -1.92 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | $2.55 | +19.4% |
| FY2021 | $2.13 | - |
| FY2020 | - | - |
| FY2019 | -$0.09 | -150.6% |
| FY2018 | -$0.04 | -16.1% |
| FY2017 | -$0.03 | -276.1% |
| FY2016 | -$0.01 | - |
As of FY2022 · SEC 10-K · Updated Jun 30, 2026